An elevated Hsp70 expression on tumor cells has been shown to serve as a biomarker for tumor aggressiveness, therapeutic response, and overall survival (Pockley and Henderson 2018; Gunther et al. 2015; Chanteloup et al. 2020). The gene discussed is HSPA1A; the disease is neoplasm.